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□CASE REPORT□
Syndrome of Inappropriate Secretion of ADH (SIADH)
due to Small Cell Lung Cancer with
Extremely High Plasma Vasopressin Level
Miki MrzosucHr, Makoto KuNssrcs, Katsuyuki Kuso*, Machiko Kovarsu*, Hiroshi BnNoo and Shiro Seno
A 76-year-old man with small cell lung cancer associated with the syndrome of inappropriate
secretion of ADH (SIADH) visited our hospital. The serum Na level was normal on the first visit,
but 2 weeks later it decreased to 114 mEq/L with an extremely high plasma vasopressin (VP) level
of 1520 pg/ml. Serum Na was normalized after the reduction of the tumor size by chemotherapy,
but the plasma VP level remained between 150 to 600 pg/ml. On gel filtration of plasma VP two
peaks of immunoreactive VP were eluted at the positions of a larger molecule than authentic VP
and authentic VP, and VP in urine gave only one peak compared to that of authentic VP. The
dilution curve of plasma VP was almost parallel and that of urine was completely parallel to the
standard curve. These findings suggest that a larger VP with low physiological activity was
predominantly secreted in the present patient and manifested relatively mild symptoms despite the
extremely high plasma VP level.
(Internal Medicine 33: 501-504, 1994)
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Introduction
Syndrome of inappropriate secretion of ADH (SIADH) is
characterized by a sustained release of VP in the absence of
either osmotic or nonosmotic stimuli, and is most commonly
due to ectopic VP secretion by malignancies of several kinds.
Small cell lung cancer is known to ectopically produce various
peptide hormones including VP. We experienced a 76-year-old
man with small cell lung cancer associated with SIADH. The
SIADH disappeared and the serum Na level became normal
after reduction of the tumor size by chemotherapy, while the
plasma VP level remained rather high. On gel filtration of VP
in plasma and urine a large molecule of VP was predominantly
eluted compared to authentic VP, suggesting a low physiologi-
cal activity of this larger VP.
Case Report
A 76-year-old man visited the Anan Kyoei Hospital on
December 5, 1991 with complaints of chest pain, and cough
with sputum for three months.
His height was 146.5 cm, weight 45 kg, blood pressure, I 30/
60 mmHg, pulse 84 beats/min and regular, and body tempera-
ture 37.0'C. Neither dehydration nor edema was detected. The
lymph nodes were not palpable. No abnormal findings were
observed in his chest, abdomen and nervous system.
Laboratory tests at the time of admission revealed the
following results (Table l): urinalysis was normal, but mild
anemia was observed; BUN 17 mg/dl, serum Creatinine 0.8 mg/
dl, sodium level 145 mEq&, potassium 4.0 mEqlL, chloride
109 mg/dl, thyroid and adrenal functions were normal. The
levels of tumor markers were high (neuron-specific enolase
49.8 nglml and SCC 2.3 nglml).
The chest radiogram showed a tumor-like shadow in the left
upper lung field and a scar from pleuritis in the right lung (Fig.
I ). The chest CT scan showed a mass lesion in 53 of the left lung
and swelling of the mediastinal lymph nodes. Broncho-
fiberscopical biopsy demonstrated tumor cells of small cell
lung cancer (Fig. 2).
Two weeks after admission he developed nausea and drows-
iness, and his serum Na level decreased to I 14 mEq/L. At that
time, theplasmaVPlevel was extremely high ( 1520pg/ml), and
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Table I . Laboratory Findings on Admission (Dec. 20, l99l )
Urinalysis
ESR
Pcriphcral blood
RBC
Hb
Ht
WBC
Platclet
Blood chemistry
GOT
GP「
glucosc(―)
protcin(―)
80mm/11r
385×104/mm3
119g/dl
385%
4,790/mm3
209×104/mm3
291U/L
171U/L
TP
BUN
Creatinine
Uric acid
Na
K
CI
FBS
Tumor marker
CEA
NSE
SCC
74g/dl
17mg/dl
0 8mg/dl
63mg/dl
i45mEq/L
4 0mEq/L
109mEq/L
102mg/dl
3 7ng/ml
48 9ng/ml
2 3ng/1111
FBS: fasting blood sugar, CEA: carcinoembryonic antigen, NSE: neuron-
specific enolase. SCC: squamous cell carcinoma-related antigen.
Fig. l. Chest X-ray Iilm on admission showing tumor-like
shadow at the left hilar area.
he was diagnosed as SIADH (Table 2). With three episodes of
chemotherapy using carboplatin (CBDCA), etoposide (VP-
l6), doxorubicin hydrochloride (ADM), vincristine sulfate
(VCR), and cyclophosphamide (CPA) for the lung cancer, the
tumor shadow was reduced and the serum Na level was norrnal-
ized. The plasma VP level also decreased, but remained be-
tween 150 and 600 pglml until September 1992 when he died
without any symptoms of SIADH. The lung cancer had en-
larged again, metastasized to the cervical spine and liver, and he
died of sudden melena and arrhythmia on September 2, 1992
(Fig. 3).
Materials and Methods
To clarify the discrepancy between the high plasma VP level
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Fig. 2. Histology of the lung tumor showing small cell lung cancer,
intermediate type (HE stain, x200).
Table 2. Laboratory Findings on Jan. 2, 1992 when the Diagnosis ofSIADH
was Made
Blood chemistv
BUN          6mydl
Crcatininc      05mg/dl
Uric acid 1 4mydl
Na         H4mEq/L
K          4.lmEq/L
C1           83mEq/L
Posm       225mOsm/kg
Uosm       468mOsm/kg
Hormonal examination
VP
GH
PRL
TSH
LH
FSH
ACTH          31pg/ml
co■isol        16 4μg/dl
1,520pg/ml
3 9ng/1nl
12nゴml
1 8μU/ml
15mIU/ml
7 5mIU/ml
Urine Na 79.8mEq/day PRA 0 9ng/m1/hr
(urine volume 500mI/day) aldosterone 30p9,/ml
and no SIADH symptoms after March 1992, we investigated
the gel filtration pattern of immunoreactive VP (IR-VP) in the
plasma and urine. VP was extracted from plasma collected on
January 2,1992 by the method of Shimizu and colleagues (l).
Briefly, the plasma sample was placed on a Sep-Pak-Cl8
column (Water Associates, Milford, MA USA) and eluted with
methanol. VP concentration was measured by the AVP-RIA kit
(Mitsubishi Petrochemical Co., Tokyo, JAPAN). The recovery
of VP from the plasma was 90.27o and the sensitivity of the
assay was 0.3 pglml.
Gel filtration of VP in plasma extract and urine were per-
formed using a Sephadex G25 column (1x45 cm) and eluted
with 0.01 M phosphate buffer, pH7.4.
Results
Gel filtration pattems of IR-VP in the plasma extract and
urine are shown in Fig. 4. IR-VP in the plasma extract was
eluted at the positions of void volume, with a bigger molecule
than authentic VP and authentic VP. On the other hand, IR-VP
in the urine sample showed one peak at the position of authentic
VP. The dilution curve of IR-VP in the plasma extract was
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almost parallel to the standard curve and that of IR-VP in the
urine was completely parallel (Fig. 5).
Discussion
SIADH is a clinical entity proposed by Schwartz and col-
leagues (2) in 1957. and caused by pulmonary diseases,
cerebrospinal diseases and ectopic ADH-secreting tumors, etc.
Lung cancer occupies 84Vo of ADH-secreting tumors, with
947o as small cell lung cancer ( I ).
On the other hand, SIADH is seen in7-397o of patients with
small cell lung cancer, and hyponatremia is detected in907o of
cases at initial diagnosis (3). In the present case, the plasma VP
concentration was remarkably high, but later decreased with
reduction of the tumor after chemotherapy. These findings
suggested that the production and secretion of VP was caused
by the cancer. The present patient's serum Na level was normal
at the first visit, then two weeks later an extremely high plasma
VP level was found with SIADH. After chemotherapy the
SIADH disappeared, but the plasma VP level remained at the
levels of 150-600 pg/ml.
To clarify the reason for the discrepancy between the high
plasma VP level and normal serum Na level, the nature of the
plasma VP was investigated. Gel filtration study showed two
peaks of plasma IR-VP besides a molecule at the position of the
void volume, a large VP and an authentic VP. IR-VP in the urine
gave only one peak at the position ofthe authentic VP. Further-
more, the dilution curve of plasma IR-VP was almost parallel
to the standard curve, and that of urinary IR-VP was completely
parallel. These findings suggested that the cancer predomi-
nantly produced high molecular weight VP rather than authen-
tic VP. There are some reports of gel filtration study on the
tissue extract of small cell lung cancer with SIADH. In compari-
Dilution of urine
son with these studies, the present case is characteristic for its
extremely high plasma VP level, and the different elution
pattern of the IR-VP in the plasma and urine. A high molecular
weight VP in the present case seemed to be smaller in molecular
size than the VPprecursor (high molecular weight neurophysin)
reported by Yamaji and colleagues (4) and to have almost the
same size as the neurophysin fragment attached to the C-
terminus of VP (5). Plural enzymes participate in the complete
conversion of the precursor to VP and neurophysin (4). This
large VP produced by the tumor may be processed in a different
manner from authentic VP. Furtherrnore, the ratio of large VP
to authentic VP was higher in the present case compared to the
case reported by Shimizu (l ). The physiological activity of this
large VP is not known, but should be much lower than authentic
VP. The structure and physiological activity of this large VP
remains to be studied.
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Fig. 5. Standard curve of VP radioimmunoassay and the dilution curves of IR-VP in plasma extract
and urine.
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